机构

• 上海药物研究所 [2]
• 广州地球化学研究所 [1]

采集方式

• OAI收割 [3]

内容类型

• 期刊论文 [3]

发表日期

• 2025 [1]
• 2024 [1]
• 2022 [1]

学科主题

筛选

浏览/检索结果: 共3条，第1-3条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序作者升序作者降序 Pharmacokinetics and Safety of TPN171 (a PDE5 Inhibitor) in Patients With Mild or Moderate Hepatic Impairment Versus Participants With Normal Hepatic Function: A Phase I Study 期刊论文  OAI收割 CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2025, 页码: 7 作者:  Zhou, Jing;  Zhang, Hong;  Ding, Yanhua;  Wang, Zhen;  Wang, Yu   |  收藏  |  浏览/下载：2/0  |  提交时间：2025/06/23 hepatic impairment  pharmacokinetics  phosphodiesterase-5 inhibitor  TPN171   Polystyrene microplastics exposure: Disruption of intestinal barrier integrity and hepatic function in infant mice 期刊论文  OAI收割 ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 2024, 卷号: 288, 页码: 10 作者:  Li, Huan;  Xu, Shimin;  Zhou, Feng;  Liu, Su;  Zhang, Dong   |  收藏  |  浏览/下载：21/0  |  提交时间：2025/04/01 Polystyrene microplastics (PSMPs)  Infant mice  Oral exposure  Intestinal barrier impairment  Hepatic injury   Changes in Disposition of Ezetimibe and Its Active Metabolites Induced by Impaired Hepatic Function: The Influence of Enzyme and Transporter Activities 期刊论文  OAI收割 PHARMACEUTICS, 2022, 卷号: 14, 期号: 12, 页码: 22 作者:  Xie, Ningjie;  Wang, Hong;  Qin, Hua;  Guo, Zitao;  Xue, Hao   |  收藏  |  浏览/下载：32/0  |  提交时间：2023/04/10 hepatic impairment  ezetimibe  active metabolites  phase II enzymes  transporters  first-pass metabolism  inhibitory bile acids